Blocking P2Y2 purinergic receptor prevents the development of lipopolysaccharide-induced acute respiratory distress syndrome
Acute respiratory distress syndrome (ARDS) is associated with high morbidity and mortality resulting from a direct or indirect injury of the lung. It is characterized by a rapid alveolar injury, lung inflammation with neutrophil accumulation, elevated permeability of the microvascular-barrier leadin...
Main Authors: | Zahra Kargarpour, Sanja Cicko, Thomas C. Köhler, Andreas Zech, Slagjana Stoshikj, Christina Bal, Andreas Renner, Marco Idzko, Ahmed El-Gazzar |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1310098/full |
Similar Items
-
Cell-type-specific role of P2Y2 receptor in HDM-driven model of allergic airway inflammation
by: Dominik Schneble, et al.
Published: (2023-09-01) -
Microglia and Neuroinflammation: What Place for P2RY12?
by: Albert Gómez Morillas, et al.
Published: (2021-02-01) -
Traditional Chinese medicine alleviating neuropathic pain targeting purinergic receptor P2 in purinergic signaling: A review
by: Bo Yang, et al.
Published: (2023-11-01) -
A Systematic Review of the Role of Purinergic Signalling Pathway in the Treatment of COVID-19
by: Vitoria Guero Korb, et al.
Published: (2023-04-01) -
Editorial: Purinergic pharmacology, Volume II
by: Francisco Ciruela, et al.
Published: (2023-05-01)